Arbutus Biopharma Corp
ABUS
$4.29+2.39%
End of day · as of Oct 16, 2026, 8:00 AM ET
Mkt cap
$882.99M
EV/Sales
61.4
P/E ratio
N/A
FY2025 Revenue
$14.08M
EPS (H1 2026)
$0.84
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-237.88%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Latest reported ABUS revenue for 2025-12-31 was $14.1M. Net income was -$33.5M. Revenue was up 128.2% from 2024-12-31 to 2025-12-31. ABUS currently screens at market cap $883.0M.
Use this ABUS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ABUS income, balance, and cash tables.
Arbutus Biopharma Corp (ABUS) is a biotechnology company in the Healthcare sector.
Latest cached Arbutus Biopharma Corp (ABUS) revenue for Dec 31, 2025 was $14.1M. Net income was -$33.5M. Statements: https://lician.com/financials/abus
Arbutus Biopharma Corp (ABUS) market capitalization is $883.0M on the latest cached snapshot.
Arbutus Biopharma Corp (ABUS) cached previous close $4.19; day range $4.23 – $4.29; volume 2,260,188. Session quote: https://lician.com/quote/abus
Arbutus Biopharma Corp (ABUS) latest cached earnings event is "ABUS earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ABUS filing is 8-K · Oct 22, 2026. Filings: https://lician.com/sec/abus